Skip to main content
. 2020 Jul 19;8(1):e001424. doi: 10.1136/bmjdrc-2020-001424

Table 1.

Anthropometric and demographic data and biochemical parameters of the control group, children with type 1 diabetes, and children with obesity

Control group
n=46
Children with type 1 diabetes n=49 Children with obesity
n=40
ANOVA
P value Post hoc
Age (years) 12.46
(11.38–13.54)
12.66
(11.57–13.74)
13.01
(11.79–14.24)
NS
Male/female (%) 56/44 57/43 45/55 NS
Tanner stage (n) Distribution by age group
<10 years: 11
(2 males/9 females)
10–13 years: 13
(9 males/4 females)
>13 years: 22
(15 males/7 females)
Distribution by Tanner stage
Tanner I: 13
(3 males/10 females)
Tanner II: 9
(9 females)
Tanner III: 1
(1 female)
Tanner IV: 4
(4 males)
Tanner V: 22
(13 males/9 females)
Distribution by Tanner stage
Tanner I: 11
(8 males/3 females)
Tanner II: 9
(6 males/3 females)
Tanner III: 2
(1 male/1 female)
Tanner IV: 4
(1 male/3 females)
Tanner V: 14
(3 males/11 females)
NS (between children with type 1 diabetes and with obesity)
BMI (Z-score) −0.25
(−0.42/−0.09)
0.05
(−0.27 to 0.36)
4.87
(4.44–5.35)
<0.001 1–3***
2–3***
Waist circumference
(Z-score)
0.29
(0.08–0.61)
0.44
(0.05–0.83)
5.99
(5.32–6.81)
<0.001 1–3***
2–3***
Cholesterol
(mg/dL)
158.5
(152.58–164.51)
160.1
(154.02–166.25)
148.7
(139.65–157.80)
NS
HDL cholesterol
(mg/dL)
48.1
(44.56–51.67)
58.1
(54.80–61.48)
43.0
(40.23–45.87)
<0.001 1–2***
2–3***
1–3*
Non-HDL cholesterol
(mg/dL)
110.4
(105.5–115.4)
97.8
(89.6–106.1)
104.3
(95.8–112.8)
<0.05 1–2*
2–3*
LDL cholesterol
(mg/dL)
95.6
(90.59–100.62)
89.4
(83.89–95.02)
89.2
(80.90–97.45)
NS
Triglycerides
(mg/dL)
74.09
(68.60–79.57)
61.57
(54.63–71.14)
95.28
(81.14–109.41)
<0.001 1–2*
1–3*
2–3***

*P<0.05; **p<0.01; ***p<0.001

ANOVA, analysis of variance; BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NS, not significant.